Stuart Gitlow, MD, Elected President of the American Society of Addiction Medicine

Dr. Gitlow is a committed educator in addiction medicine whose goal is to cultivate students’ interest in addiction medicine through academic rigor.

New York, NY
 – April 25, 2013 /Press Release/  –– 

Stuart Gitlow, MD, MPH, MBA, FAPA, has been named President of the American Society of Addiction Medicine (ASAM). His presidency was made official at the 44th Annual Medical-Scientific Conference in Chicago this spring and will be effective through April 2015.

ASAM is a professional society representing more than 3,000 physicians dedicated to increasing access and improving quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addictions.

"Addictive disease has directly impacted 10-15 percent of the public, but we are in a more dangerous time than ever,” said Dr. Gitlow, who is an Associate Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. “Pill mills across the country are prescribing high dose narcotics to patients for whom such prescriptions are unwarranted. Some third parties are not allowing appropriate medication to be prescribed to patients with opioid use disorders. We've made great strides with tobacco use; it is time to apply what we've learned from that battle to these other areas of the field. I am honored to lead the charge in these areas as president of the ASAM.”

Dr. Gitlow is a committed educator in addiction medicine whose goal is to cultivate students’ interest in addiction medicine through academic rigor. To that end, he founded and is now Executive Director of the Annenberg Physician Training Program in Addictive Disease at Mount Sinai. He serves as Co-Chair of the American Medical Association’s (AMA) Action Team on Alcohol and Health, and as an elected member of the AMA’s Council on Science and Public Health. Board certified in general, addiction, and forensic psychiatry, Dr. Gitlow has an active addiction medicine practice.

A graduate of Massachusetts Institute of Technology and Mount Sinai, Dr. Gitlow’s psychiatric and public health training took place at the University of Pittsburgh, after which he attended Harvard for his forensic fellowship. Now dividing his time between his clinical practice in New England and his academic work in New York City, he is on faculty at Mount Sinai and at Dartmouth, where he is Adjunct Instructor in Psychiatry.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine is one of the leading medical schools in the United States, with more than 3,400 faculty in 32 departments and 14 research institutes. It ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report. The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation’s top hospitals based on reputation, safety, and other patient-care factors. 
 
For more information, visit http://www.mountsinai.org. 
Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
 
# # #